A detailed history of Sierra Summit Advisors LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Sierra Summit Advisors LLC holds 13,536 shares of ABBV stock, worth $2.41 Million. This represents 0.61% of its overall portfolio holdings.

Number of Shares
13,536
Previous 12,097 11.9%
Holding current value
$2.41 Million
Previous $2.07 Billion 28.83%
% of portfolio
0.61%
Previous 0.51%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$163.84 - $199.33 $235,765 - $286,835
1,439 Added 11.9%
13,536 $2.67 Billion
Q2 2024

Aug 09, 2024

BUY
$154.79 - $180.76 $178,782 - $208,777
1,155 Added 10.56%
12,097 $2.07 Billion
Q1 2024

May 09, 2024

BUY
$159.82 - $182.1 $4,634 - $5,280
29 Added 0.27%
10,942 $1.99 Billion
Q4 2023

Feb 22, 2024

BUY
$137.6 - $154.97 $1.5 Million - $1.69 Million
10,913 New
10,913 $1.69 Billion

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $315B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Sierra Summit Advisors LLC Portfolio

Follow Sierra Summit Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sierra Summit Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sierra Summit Advisors LLC with notifications on news.